Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis

Purpose. To report favorable outcome of a case of acute posterior multifocal placoid pigment epitheliopathy (APMPPE) associated with cerebral vasculitis after treatment with immunosuppressive therapy by mitoxantrone. Design. Single case report. Method. A 22-year-old man presented with acute isolated...

Full description

Saved in:
Bibliographic Details
Main Authors: Hélène Massé, Jean-Laurent Guyomard, Dominique Baudet, Jean-François Pinel, Gilles Edan, Jean-François Charlin
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2009/481512
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558568899870720
author Hélène Massé
Jean-Laurent Guyomard
Dominique Baudet
Jean-François Pinel
Gilles Edan
Jean-François Charlin
author_facet Hélène Massé
Jean-Laurent Guyomard
Dominique Baudet
Jean-François Pinel
Gilles Edan
Jean-François Charlin
author_sort Hélène Massé
collection DOAJ
description Purpose. To report favorable outcome of a case of acute posterior multifocal placoid pigment epitheliopathy (APMPPE) associated with cerebral vasculitis after treatment with immunosuppressive therapy by mitoxantrone. Design. Single case report. Method. A 22-year-old man presented with acute isolated bilateral loss of vision revealing APMPPE. Corticosteroid therapy was initiated and visual acuity gradually improved. Seventeen days later, visual function deteriorated again, associated with flu-like syndrome and severe headaches. A relapse of APMPPE was diagnosed, complicated with lymphocytic meningitis and cerebral ischemia. Intravenous therapy with mitoxantrone was performed in combination with methylprednisolone. Results. Headaches disappeared in a few days whereas visual acuity gradually improved and stabilized at 20/40 in the right eye and 20/32 in the left eye. No adverse event was observed. Clinical improvement was confirmed by magnetic resonance imaging. Conclusion. Cerebral vasculitis is the most severe complication of the extraocular manifestations of APMPEE. This diagnosis should be evoked when severe headaches or behavior disorder are associated with APMPEE.
format Article
id doaj-art-1321e1126be04375a1fa3f7dfb52fd83
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-1321e1126be04375a1fa3f7dfb52fd832025-02-03T01:32:03ZengWileyCase Reports in Medicine1687-96271687-96352009-01-01200910.1155/2009/481512481512Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral VasculitisHélène Massé0Jean-Laurent Guyomard1Dominique Baudet2Jean-François Pinel3Gilles Edan4Jean-François Charlin5Service d'ophtalmologie, CHU Pontchaillou, rue Henri Le Guilloux, 35000 Rennes, FranceService d'ophtalmologie, CHU Pontchaillou, rue Henri Le Guilloux, 35000 Rennes, FranceService d'ophtalmologie, CHU Pontchaillou, rue Henri Le Guilloux, 35000 Rennes, FranceService de neurologie, CHU Pontchaillou, rue Henri Le Guilloux, 35000 Rennes, FranceService de neurologie, CHU Pontchaillou, rue Henri Le Guilloux, 35000 Rennes, FranceService d'ophtalmologie, CHU Pontchaillou, rue Henri Le Guilloux, 35000 Rennes, FrancePurpose. To report favorable outcome of a case of acute posterior multifocal placoid pigment epitheliopathy (APMPPE) associated with cerebral vasculitis after treatment with immunosuppressive therapy by mitoxantrone. Design. Single case report. Method. A 22-year-old man presented with acute isolated bilateral loss of vision revealing APMPPE. Corticosteroid therapy was initiated and visual acuity gradually improved. Seventeen days later, visual function deteriorated again, associated with flu-like syndrome and severe headaches. A relapse of APMPPE was diagnosed, complicated with lymphocytic meningitis and cerebral ischemia. Intravenous therapy with mitoxantrone was performed in combination with methylprednisolone. Results. Headaches disappeared in a few days whereas visual acuity gradually improved and stabilized at 20/40 in the right eye and 20/32 in the left eye. No adverse event was observed. Clinical improvement was confirmed by magnetic resonance imaging. Conclusion. Cerebral vasculitis is the most severe complication of the extraocular manifestations of APMPEE. This diagnosis should be evoked when severe headaches or behavior disorder are associated with APMPEE.http://dx.doi.org/10.1155/2009/481512
spellingShingle Hélène Massé
Jean-Laurent Guyomard
Dominique Baudet
Jean-François Pinel
Gilles Edan
Jean-François Charlin
Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis
Case Reports in Medicine
title Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis
title_full Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis
title_fullStr Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis
title_full_unstemmed Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis
title_short Mitoxantrone Therapy for Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis
title_sort mitoxantrone therapy for acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitis
url http://dx.doi.org/10.1155/2009/481512
work_keys_str_mv AT helenemasse mitoxantronetherapyforacuteposteriormultifocalplacoidpigmentepitheliopathywithcerebralvasculitis
AT jeanlaurentguyomard mitoxantronetherapyforacuteposteriormultifocalplacoidpigmentepitheliopathywithcerebralvasculitis
AT dominiquebaudet mitoxantronetherapyforacuteposteriormultifocalplacoidpigmentepitheliopathywithcerebralvasculitis
AT jeanfrancoispinel mitoxantronetherapyforacuteposteriormultifocalplacoidpigmentepitheliopathywithcerebralvasculitis
AT gillesedan mitoxantronetherapyforacuteposteriormultifocalplacoidpigmentepitheliopathywithcerebralvasculitis
AT jeanfrancoischarlin mitoxantronetherapyforacuteposteriormultifocalplacoidpigmentepitheliopathywithcerebralvasculitis